• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期高血压的表型管理

Phenotype-Directed Management of Hypertension in Pregnancy.

机构信息

Department of Obstetrics and Gynecology Division of Maternal-Fetal Medicine Sinai Health SystemUniversity of Toronto Toronto Canada.

Department of Obstetrics and Gynecology Division of Maternal-Fetal Medicine University of Washington Medical Center Seattle WA.

出版信息

J Am Heart Assoc. 2022 Apr 5;11(7):e023694. doi: 10.1161/JAHA.121.023694. Epub 2022 Mar 14.

DOI:10.1161/JAHA.121.023694
PMID:35285667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075436/
Abstract

Hypertensive disorders of pregnancy are among the most serious conditions that pregnancy care providers face; however, little attention has been paid to the concept of tailoring clinical care to reduce associated adverse maternal and perinatal outcomes based on the underlying disease pathogenesis. This narrative review discusses the integration of phenotype-based clinical strategies in the management of high-risk pregnant patients that are currently not common clinical practice: real-time placental growth factor testing at Mount Sinai Hospital, Toronto and noninvasive hemodynamic monitoring to guide antihypertensive therapy at the University of Washington Medical Center, Seattle. Future work should focus on promoting more widespread integration of these novel strategies into obstetric care to improve outcomes of pregnancies at high risk of adverse maternal-fetal outcomes from these complications of pregnancy.

摘要

妊娠高血压疾病是妊娠保健提供者面临的最严重的疾病之一;然而,基于潜在的疾病发病机制,针对减少相关不良母婴围产结局的临床护理定制问题,尚未得到足够的重视。本综述讨论了将基于表型的临床策略整合到高危孕妇管理中的问题,目前这还不是常规临床实践:西奈山医院(多伦多)的实时胎盘生长因子检测和华盛顿大学医学中心(西雅图)的无创血流动力学监测以指导降压治疗。未来的工作应重点推动将这些新策略更广泛地纳入产科护理,以改善高危妊娠母婴结局不良的妊娠的结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/49398b0d08a3/JAH3-11-e023694-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/aa0ed8826870/JAH3-11-e023694-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/d4f7caaeebea/JAH3-11-e023694-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/af6bb1994df9/JAH3-11-e023694-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/e3cd327f7bdd/JAH3-11-e023694-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/2dae79cfe972/JAH3-11-e023694-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/49398b0d08a3/JAH3-11-e023694-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/aa0ed8826870/JAH3-11-e023694-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/d4f7caaeebea/JAH3-11-e023694-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/af6bb1994df9/JAH3-11-e023694-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/e3cd327f7bdd/JAH3-11-e023694-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/2dae79cfe972/JAH3-11-e023694-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6e5/9075436/49398b0d08a3/JAH3-11-e023694-g004.jpg

相似文献

1
Phenotype-Directed Management of Hypertension in Pregnancy.妊娠期高血压的表型管理
J Am Heart Assoc. 2022 Apr 5;11(7):e023694. doi: 10.1161/JAHA.121.023694. Epub 2022 Mar 14.
2
Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.用于预测慢性高血压孕妇不良结局的血管生成标志物及其纵向变化。
Am J Obstet Gynecol. 2021 Sep;225(3):305.e1-305.e14. doi: 10.1016/j.ajog.2021.03.041. Epub 2021 Apr 1.
3
Obstetrical complications associated with abnormal maternal serum markers analytes.与母体血清标志物分析物异常相关的产科并发症。
J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5.
4
[Expert consensus on the diagnosis and treatment of obstructive sleep apnea in women].[女性阻塞性睡眠呼吸暂停诊断与治疗专家共识]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Jun 12;47(6):509-528. doi: 10.3760/cma.j.cn112147-20240206-00072.
5
Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.利用 19 至 23 周评估的超声和血管生成标志物来辅助子痫前期的后续诊断。
Am J Obstet Gynecol. 2022 Aug;227(2):294.e1-294.e11. doi: 10.1016/j.ajog.2022.03.007. Epub 2022 Mar 9.
6
A placenta clinic approach to the diagnosis and management of fetal growth restriction.胎盘门诊在胎儿生长受限的诊断和管理中的应用。
Am J Obstet Gynecol. 2018 Feb;218(2S):S803-S817. doi: 10.1016/j.ajog.2017.11.575. Epub 2017 Dec 15.
7
Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing?抗高血压药物对未出生胎儿的影响:已知情况以及这应如何影响处方开具?
Paediatr Drugs. 2000 Nov-Dec;2(6):419-36. doi: 10.2165/00128072-200002060-00002.
8
Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.胎盘生长因子检测评估疑似子痫前期的妇女:一项多中心、实用、阶梯式楔形集群随机对照试验。
Lancet. 2019 May 4;393(10183):1807-1818. doi: 10.1016/S0140-6736(18)33212-4. Epub 2019 Apr 1.
9
Fetal Growth Restriction in Hypertensive vs. Heavy Smoking Women-Placental Pathology, Ultrasound Findings, and Pregnancy Outcomes.高血压与重度吸烟孕妇的胎儿生长受限-胎盘病理、超声表现和妊娠结局。
Reprod Sci. 2021 Mar;28(3):819-827. doi: 10.1007/s43032-020-00373-6. Epub 2020 Nov 2.
10
Absolute Risk of Adverse Obstetric Outcomes Among Twin Pregnancies After In Vitro Fertilization by Maternal Age.体外受精后母亲年龄对双胎妊娠不良产科结局的绝对风险。
JAMA Netw Open. 2021 Sep 1;4(9):e2123634. doi: 10.1001/jamanetworkopen.2021.23634.

引用本文的文献

1
Association of Periconceptional Dietary Inflammatory Index and Hypertensive Disorders of Pregnancy and Its Subtype.孕前饮食炎症指数与妊娠期高血压疾病及其亚型的关联
Am J Reprod Immunol. 2025 Jul;94(1):e70122. doi: 10.1111/aji.70122.
2
The Update of Fetal Growth Restriction Associated with Biomarkers.与生物标志物相关的胎儿生长受限研究进展
Matern Fetal Med. 2022 Jul 22;4(3):210-217. doi: 10.1097/FM9.0000000000000156. eCollection 2022 Jul.
3
Rosiglitazone-Mediated Activation of PPARγ Induces PlGF Expression in Trophoblast Cells.

本文引用的文献

1
The effect of impedance cardiography directed antihypertensive therapy on fetal growth restriction rates and perinatal mortality in women with chronic hypertension.
Pregnancy Hypertens. 2022 Jun;28:123-127. doi: 10.1016/j.preghy.2022.03.006. Epub 2022 Mar 16.
2
Prospective Evaluation of International Prediction of Pregnancy Complications Collaborative Network Models for Prediction of Preeclampsia: Role of Serum sFlt-1 at 11-13 Weeks' Gestation.前瞻性评估国际妊娠并发症预测协作网络模型预测子痫前期的效果:11-13 孕周血清 sFlt-1 的作用。
Hypertension. 2022 Feb;79(2):314-322. doi: 10.1161/HYPERTENSIONAHA.121.18021. Epub 2021 Oct 25.
3
Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.母体胎盘生长因子在胎盘功能障碍高危孕妇中对低分子肝素的循环反应。
罗格列酮介导的PPARγ激活诱导滋养层细胞中胎盘生长因子(PlGF)的表达。
Reprod Sci. 2025 Apr 28. doi: 10.1007/s43032-025-01868-w.
4
Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt1): powerful new tools to guide obstetric and medical care in pregnancy.胎盘生长因子(PlGF)和可溶性fms样酪氨酸激酶-1(sFlt1):指导孕期产科和医疗护理的强大新工具。
Obstet Med. 2025 Apr 3:1753495X251327462. doi: 10.1177/1753495X251327462.
5
Effect of aerobic exercise combined with systematic nursing on psychological status and pregnancy outcomes in patients with gestational hypertension.有氧运动联合系统护理对妊娠期高血压患者心理状态及妊娠结局的影响
Am J Transl Res. 2025 Jan 15;17(1):612-621. doi: 10.62347/WWPA8609. eCollection 2025.
6
Pharmacotherapeutic options for the treatment of hypertension in pregnancy.妊娠期高血压的治疗药物选择。
Expert Opin Pharmacother. 2024 Sep;25(13):1739-1758. doi: 10.1080/14656566.2024.2398602. Epub 2024 Sep 9.
7
Pulse Pressure as a Hemodynamic Parameter in Preeclampsia with Severe Features Accompanied by Fetal Growth Restriction.脉压作为重度子痫前期伴胎儿生长受限的血流动力学参数
J Clin Med. 2024 Jul 24;13(15):4318. doi: 10.3390/jcm13154318.
Am J Obstet Gynecol. 2022 Feb;226(2S):S1145-S1156.e1. doi: 10.1016/j.ajog.2021.08.027. Epub 2021 Aug 27.
4
Pre-eclampsia.子痫前期。
Lancet. 2021 Jul 24;398(10297):341-354. doi: 10.1016/S0140-6736(20)32335-7. Epub 2021 May 27.
5
PlGF (Placental Growth Factor) Testing in Clinical Practice: Evidence From a Canadian Tertiary Maternity Referral Center.胎盘生长因子(PlGF)检测在临床实践中的应用:来自加拿大一家三级妇产转诊中心的证据。
Hypertension. 2021 Jun;77(6):2057-2065. doi: 10.1161/HYPERTENSIONAHA.121.17047. Epub 2021 Apr 12.
6
Preventing Recurrent Preeclampsia by Tailored Treatment of Nonphysiologic Hemodynamic Adjustments to Pregnancy.通过针对妊娠非生理性血液动力学调节的个体化治疗预防子痫前期复发。
Hypertension. 2021 Jun;77(6):2045-2053. doi: 10.1161/HYPERTENSIONAHA.120.16502. Epub 2021 Apr 5.
7
Clustering Longitudinal Blood Pressure Trajectories to Examine Heterogeneity in Outcomes Among Preeclampsia Cases and Controls.聚类纵向血压轨迹,以检查子痫前期病例和对照组结局的异质性。
Hypertension. 2021 Jun;77(6):2034-2044. doi: 10.1161/HYPERTENSIONAHA.120.16239. Epub 2021 Apr 5.
8
Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.利用临床、生化和超声标志物预测子痫前期的模型的验证和建立:一项个体参与者数据荟萃分析。
Health Technol Assess. 2020 Dec;24(72):1-252. doi: 10.3310/hta24720.
9
Placental growth factor in suspected preterm pre-eclampsia: a review of the evidence and practicalities of implementation.疑似早产子痫前期中的胎盘生长因子:对证据的回顾和实施的实际情况。
BJOG. 2020 Dec;127(13):1590-1597. doi: 10.1111/1471-0528.16425. Epub 2020 Aug 26.
10
Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study.实施常规早孕期子痫前期联合筛查:一项临床有效性研究。
BJOG. 2021 Jan;128(2):149-156. doi: 10.1111/1471-0528.16361. Epub 2020 Jul 1.